IRIS
MADEDDU, Denise
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.237
AS - Asia 2.604
EU - Europa 2.136
SA - Sud America 322
AF - Africa 110
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.416
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.152
SG - Singapore 847
CN - Cina 803
IT - Italia 472
VN - Vietnam 426
SE - Svezia 362
IE - Irlanda 354
BR - Brasile 249
DE - Germania 218
FI - Finlandia 215
HK - Hong Kong 190
FR - Francia 124
ZA - Sudafrica 78
TR - Turchia 77
NL - Olanda 66
GB - Regno Unito 65
IN - India 64
AT - Austria 56
CA - Canada 49
UA - Ucraina 41
BE - Belgio 40
BD - Bangladesh 34
CZ - Repubblica Ceca 28
MX - Messico 27
IQ - Iraq 26
AR - Argentina 24
JP - Giappone 23
RU - Federazione Russa 22
PL - Polonia 21
EC - Ecuador 16
PK - Pakistan 15
PH - Filippine 14
LT - Lituania 13
CO - Colombia 11
ID - Indonesia 11
CI - Costa d'Avorio 10
TH - Thailandia 10
MA - Marocco 9
VE - Venezuela 9
JO - Giordania 8
RO - Romania 8
UZ - Uzbekistan 8
ES - Italia 7
KR - Corea 7
AZ - Azerbaigian 5
CH - Svizzera 5
OM - Oman 5
TN - Tunisia 5
TW - Taiwan 5
AL - Albania 4
AU - Australia 4
NP - Nepal 4
UY - Uruguay 4
KE - Kenya 3
MY - Malesia 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
EU - Europa 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
KH - Cambogia 2
PE - Perù 2
RS - Serbia 2
SY - Repubblica araba siriana 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
MT - Malta 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.416
Salva come PNG Salva come JPEG
Città #
Singapore 483
Ashburn 411
Chandler 395
Dublin 354
San Jose 242
Dallas 208
Ann Arbor 186
Parma 181
Hong Kong 178
Beijing 165
Santa Clara 165
Ho Chi Minh City 126
Boardman 118
Dearborn 112
New York 94
Hanoi 86
Shanghai 82
Munich 76
Nanjing 76
Johannesburg 75
Los Angeles 70
Izmir 58
Padova 57
Lauterbourg 55
Princeton 54
Bremen 49
Vienna 49
Wilmington 45
Helsinki 43
Jacksonville 43
Brussels 40
Nanchang 31
Buffalo 30
Jinan 28
São Paulo 27
Haiphong 25
Hebei 24
Columbus 21
Seattle 21
Milan 19
Brooklyn 18
San Mateo 18
Frankfurt am Main 17
Hefei 17
London 17
Pune 17
Shenyang 17
Tokyo 17
Toronto 17
Council Bluffs 16
Des Moines 16
Guangzhou 16
Jiaxing 16
Kunming 16
Rio Saliceto 16
Turku 16
Warsaw 16
Changsha 14
Da Nang 14
Fremont 13
Norwalk 13
Brno 12
Houston 12
Moscow 12
Zhengzhou 12
Baghdad 11
Denver 11
Hải Dương 11
Stockholm 11
The Dalles 11
Tianjin 11
Abidjan 10
Atlanta 10
Montreal 10
Nuremberg 10
Redmond 10
Tulsa 10
Chennai 9
Hangzhou 9
Woodbridge 9
Mexico City 8
Modena 8
Olomouc 8
Rio de Janeiro 8
Amman 7
Boston 7
Can Tho 7
Falkenstein 7
Jakarta 7
Phoenix 7
Curitiba 6
Falls Church 6
Guayaquil 6
Haikou 6
Kocaeli 6
Lahore 6
Marseille 6
Orem 6
Redwood City 6
Amsterdam 5
Totale 5.273
Salva come PNG Salva come JPEG
Nome #
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 259
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 215
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 209
L’autofagia coinvolge i cardiomiociti e le cellule progenitrici nella cardiomiopatia indotta da imatinib mesilato 200
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 193
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 188
Lymphangiogenesis in genetically determined hypertrophic obstructive cardiomyopathy 186
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 182
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 182
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 180
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 179
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 177
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 176
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 176
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 176
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 173
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 173
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? 170
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 168
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 167
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 165
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 161
Assessment of Cardiac Patches Suitability for Tissue Engineering 158
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN 156
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 155
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 154
Potential involvement of cardiac and bone marrow vascular progenitors in imatinib induced cardiovascular toxicity 153
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 152
Isolation and characterization of human lung lymphatic endothelial cells 151
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 150
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 149
Resident cardiac stem cells. 145
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 145
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 144
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 144
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 143
Stem cells and myocardial regeneration 142
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 141
Tyrosine kinase cardiotoxicity: ultrastructural analysis of imatinib mesylate induced cardiomyopathy 140
Development of biomimetic alginate/gelatin/elastin sponges with recognition properties toward bioactive peptides for cardiac tissue engineering 133
Biomimetic poly(glycerol sebacate) (PGS) membranes for cardiac patch application 126
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 124
SURGICAL SAMPLING IS AN EMERGING ISSUE IN THE ASSESSMENT OF THE IMMUNE CONTEXTURE IN NON SMALL CELL LUNG CANCER (NSCLC) 123
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 123
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 122
IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium 115
Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture 114
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 108
Low vagally-mediated heart rate variability and increased susceptibility to ventricular arrhythmias in rats bred for high anxiety. 105
Correction: A versatile bioreactor for dynamic suspension cell culture. Application to the culture of cancer cell spheroids 105
LUNG MESENCHYMAL STEM CELLS FUNCTION AS THE INDUCTIVE MICROENVIRONMENT FOR HUMAN LUNG CANCER PROPAGATING CELLS 104
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 103
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 102
Influence of injectable microparticle size on cardiac progenitor cell response 101
Reinforced alginate/gelatin sponges functionalized by avidin/biotin-binding strategy: a novel cardiac patch 89
In vitro suspension bioreactor-based platform for culturing tumor cell clusters 84
Thermoreversible injectable polyurethane hydrogels: future challenges for biomedical applications 71
Transcriptomic analysis reveals lipid metabolism and macrophage involvement associated with nintedanib treatment in a rat bleomycin model 20
Totale 8.549
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 0 0 0 0 0 0 0 0 25 55 18
2021/2022273 17 11 9 14 4 10 39 21 12 21 11 104
2022/20231.524 160 186 102 121 160 156 37 81 428 10 69 14
2023/2024566 22 41 8 16 50 152 51 24 17 46 66 73
2024/20251.418 29 71 102 114 164 125 82 71 134 121 139 266
2025/20263.024 334 256 366 295 447 176 342 113 451 244 0 0
Totale 8.549